U.S. market Open. Closes in 5 hours 12 minutes

EMBC | Embecta Corp. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 11.94 - 12.88
52 Week Range 9.93 - 21.48
Beta 0.61
Implied Volatility 60.91%
IV Rank 26.66%
Day's Volume 571,168
Average Volume 534,464
Shares Outstanding 58,134,434
Market Cap 741,214,034
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2022-03-22
Valuation
Profitability
Growth
Health
P/E Ratio 12.88
Forward P/E Ratio 5.95
EPS 0.99
1YR Price Target 29.00
Dividend Yield 4.89%
Dividend Per Share 0.62
Dividend ExDate N/A
Dividend PayDate N/A
Employees 2,200
Country USA
Website EMBC
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
EMBC's peers: ALC, BAX, ISRG, RMD, WST, COO, ICUI, MMSI, ANGO, ATR, TFX, HAE, NVST, AKYA, ATRC, ATRI
*Chart delayed
Analyzing fundamentals for EMBC we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see EMBC Fundamentals page.

Watching at EMBC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on EMBC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙